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Nutrition presents unanswered scientific questions of high public health importance. We envision
model systems composed of interacting gastrointestinal and metabolic tissues derived from
human embryonic stem cells, populated by gut microbiota. The culture will be embedded in 3D
scaffolds, creating a controlled experimental system that enables tissue sampling and imaging.Introduction
In the 19th century, important advances in
physiology arose fromanunusual relation-
ship between the physician William Beau-
mont and his patient Alexis St. Martin.
St. Martin received a shotgun wound that
left him with a sizeable opening in his
stomach that did not close. Beaumont
availed himself of St. Martin’s unique con-
dition and conducted some of the first
digestion experiments. For 10 years he
continued this research combining in vivo
and in vitro approaches. For example, by
tying food to a string and inserting it
through the hole in St. Martin’s stomach
and retrieving it later, Beaumont was
able to retrieve the food and observe
digestion in real time. He also removed
gastric juice from St. Martin’s stomach
watched it digest food in a test tube,
providing new information on themechan-
ical and chemical nature of digestion.
Obviously, the scientific community has
come a long way since then, with new
methods to study physiology and nutrition
using cell lines, model organisms, and
endoscopic views of the human digestive
system. Nutritional scientists studying
microbiology, physiology, neurobiology,
immunology, epidemiology, genetics,
and behavior have made substantial
progress in understanding the biology of
food.
Nonetheless, we have yet to compre-
hensively answer some major nutritional
questions of wide public interest. For
instance, is being vegetarian beneficial
to one’s health, and if so, how? Is organi-
cally farmed food healthier or only more
expensive? How does the introduction of
new crops and cooking methods affect
our health? Can nutrition reduce risk for12 Cell 161, March 26, 2015 ª2015 Elsevier Iautoimmune diseases? Is it the high car-
bohydrate, high fat content, or both, of
western diets that leads to obesity and
metabolic syndrome? (Antico et al.,
2012; Nature Editors, 2014; Feinman
et al., 2014; Key et al., 2006)? Even in
cases with conclusive epidemiologic
data, the underlying mechanisms that
link nutrition and pathology are not
entirely clear: how does obesity lead to
development of insulin resistance? How
does a Mediterranean diet prevent car-
diovascular disease (Estruch et al., 2013;
Qatanani and Lazar, 2007; Ye et al.,
2012)? These unanswered questions
lend themselves to nutritional myths and
inconclusive recommendations that have
become all too commonplace in the daily
news. As a result, the public is easily
confused by opposing views supported
by scientific evidence (Malik and Hu,
2007; Matarese and Pories, 2014; Willett
and Stampfer, 2013).
Nutritional questions may be easy to
pose, but they are difficult to answer for
reasons we outline below. Here, we pro-
pose a stem-cell-centric point of view
and suggest that human stem cell models
of digestive processes could be a power-
ful experimental system to study the
physiology of digestion and nutrition in
the future.
Challenges in Nutritional Science
Many discoveries in physiology have
been made possible by the use of model
organisms, including fish, rodents, and
flies. Advanced experimental tools were
developed to study these organisms,
and they will continue to provide invalu-
able data for many years to come. How-
ever, since each species evolved tonc.respond to distinct nutritional challenges,
their responses to food differ; indeed, our
diet and lifestyle are strikingly different
from those of model organisms. More-
over, most model organisms have limited
genetic and environmental variability. On
the other hand, primary and immortalized
human cell lines are easy to manipulate,
are amenable to imaging and screening,
and provide highly reproducible results.
Yet, immortalized cell lines differ metabol-
ically from cells in vivo and are limited in
their ability to teach us about the function
of organs and the intra and inter-organ
signaling.
Digestion is a complex process per-
formed physically and chemically by the
gastrointestinal (GI) organs and exocrine
glands together with gut bacteria. Food
is sensed in the gut by enteroendocrine
cells that prepare the body for the
incoming meal: For example, the hor-
mone Cck regulates the release of
pancreatic enzymes, Pyy signals to neu-
rons that regulate satiety and behavior,
Glp1 sensitizes insulin-secreting cells
in anticipation for the increase in blood
glucose (Psichas et al., 2015). The im-
mune system sustains a symbiotic rela-
tionship with gut bacteria necessary for
digestion (Round and Mazmanian, 2009),
and the enteric and nervous systems
regulate gut motility, behavior, and blood
circulation through chemical and physical
sensing of food. Metabolites themselves
act as signaling molecules, capable of
binding nuclear receptors such as the
PPAR proteins. All cells consume metab-
olites and change their cell biology in
accordance with food availability, linking
nutrition to every process in the body
and making nutrition a Gordian knot.
Variability between individuals must
be taken into account. Not only do we
have different eating habits and taste
preferences, but we also vary in our
ability to digest and metabolize food.
Metabolic variability of individuals is
largely unexplored and may be affected
by numerous factors, including culture,
psychology, genetics, gut microbiome
composition, epigenetics, and neuroen-
docrine regulation.
Given these difficulties, how might one
begin to systematically tackle the ques-
tion of how nutrition affects health?
Although we cannot literally create a win-
dow into the human gut to obtain Beau-
mont’s view, researchers today would
benefit from direct access to the human
gut. Fortunately new technologies are
converging in a manner that may allow
us to recreate a functional GI system
in vitro. Our ability to generate organoids
and tissues from human embryonic stem
cells (hESCs) or induced pluripotent
stem cells (iPSCs) continues to make
rapid progress. We may soon be able to
assemble them into a miniature GI system
in a dish or even on a chip. This would
allow for the manipulation and analysis
of digestion in a reproducible, accurate,
and large-scale manner, and facilitate
exploration of the effects of individual
genetic and microbial diversity. Here we
discuss how these pieces might come
together to aid the science of nutrition.
Building a Functional
Gastrointestinal System In Vitro
Intestinal organoids are miniature, three
dimensional, star-shaped versions of the
full intestine consisting of a single epithe-
lial layer with crypts and villi. Stem cells
at the base of the crypt can be isolated
from human and mouse primary cultures,
and can generate multiple cell types, such
as pit cells, enteroendocrine cells, and
mucus glands facing a miniature lumen.
Remarkably, these organoids can be
grown for long periods of time, and
have been used by many labs now to
study in vitro digestive enzymatic activity,
development of the gut, bacterial infec-
tion, and structural aspects of the crypt-
villi unit (Sato and Clevers, 2013). Impres-
sive progress has been recently made
toward differentiating hESCs into intesti-
nal and gastric organoids (McCracken
et al., 2014; Spence et al., 2011) openinga new range of research avenues on
understanding human gut biology and
disease through the use of hESCs and
iPSCs.
Other cell types can also be differ-
entiated from hESCs. Insulin-secreting
b-cells can be grown from hESCs in clus-
ters comparable in size to an islet of Lang-
erhans (Pagliuca et al., 2014). Similarly, a
protocol for deriving glucagon-secreting
a-cells has been established (Rezania
et al., 2011). This raises the possibility of
building a human stem-cell-derived islet
(SC-islet) containing all the pancreatic
endocrine cells types. Many labs are
developing methods to differentiate
hESCs into other cell types such as adipo-
cytes (Cuaranta-Monroy et al., 2014),
hepatocytes (Takebe et al., 2013), and
myocytes (Salani et al., 2012) and find
appropriate culture conditions to keep
cells functional for extended periods of
time (Sachs and Clevers, 2014). It is likely
that we will be able to generate functional
organoids and cell types such as SC-liver
and SC-gut for most metabolic organs.
The ability to genetically modify stem
cells that are used to make the tissues
and organs will be enormously valuable
in determining which genes function
in which cells to affect phenotype. Ad-
vances in gene editing by TALEN and
CRISPR technologies make it possible
to test both loss and gain of function for
specific genes and organs.
A complementary advance has come
from bioengineering, making ‘‘organs-
on-a-chip.’’ The chips are microfluidic
devices, populated by cell cultures orga-
nized and perfused such that they
resemble tissue and organ biology more
than the classic tissue culture in a dish.
The technology aims to preserve the
advantages of cell culture, such as acces-
sibility, control, and reproducibility in an
environment that recapitulates in vivo
physiology.
In recent years we have observed a
tantalizing increase in the sophistication
of organs-on-a-chip, and an emergence
of a vibrant bioengineering community
supporting these efforts. We are still
learning how to improve upon these first
generation models, and there are several
challenges to overcome. Manufacturing
is not entirely robust, and requires exper-
tise of in-house engineers. More impor-
tantly, we are missing the functionalCell 1equivalent of blood: a medium that will
support the culture of many cell types
and transport biomolecules between
different organs. This bottleneck must be
relieved before a modular, multi-organ
system can be incorporated to study
digestion and nutrition, or any other
multi-organ process. Nonetheless, re-
searchers have been able to generate
increasingly complex functional models
of angiogenesis, blood brain barrier, car-
diovascular system, nutrient absorption,
and liver drug metabolism (Bhatia and
Ingber, 2014).
In addition, maturation of the SC-
organs remains a critical challenge for
the success of any stem-cell-derived
model. Intestinal SC-gut organoids have
improved their function after transplanta-
tion under the kidney capsule of a recip-
ient mouse (Watson et al., 2014). It is
hypothesized that vascularization is crit-
ical for this process, so proper maturation
of organs may require co-culture with
vascular endothelial cells, which can
also be derived from stem cells (van der
Meer et al., 2013).
If these challenges can bemet, it should
be possible in the future to generate an
in vitro system composed of several hu-
man ES- or iPS-derived cell types and
organoids that will absorb food from the
luminal side and be connected basally
by fluid to liver, pancreas, muscle, and/
or adipose SC-derived tissue, delivering
hormones and nutrients from one tissue
to the next (Figure 1). This would circum-
vent problems arising from using immortal
cell lines to generate organoids, as these
display altered cellular metabolism and
generally do not give rise to in vivo 3D
structures such as a liver lobule or an islet
of Langerhans. Clean human primary
cultures are difficult to obtain, especially
from many tissues at the same time.
In vitro differentiated cells overcome
these problems and can reproduce spe-
cific genetic backgrounds which can be
useful for personalizedmedicine or simply
to introduce human genetic variability into
research.
Building reliable in vitro systems
capable of recapitulating digestion is a
monumental task requiring the collab-
orative efforts of labs from several fields
in biology, chemistry, and engineering.
Some key parts of the system are missing
and integration of the stem-cell-derived61, March 26, 2015 ª2015 Elsevier Inc. 13
Figure 1. Schematic Depiction of a Human Stem-Cell Based in Vitro System to Model
Digestion and Nutrition
Food travels through different sections of the SC derived gastrointestinal segments populated by gut
microbiota. Absorbed nutrients, hormones, basally secreted proteins, and lipids are transported to an SC-
liver, which recapitulates to portal-venous axis in liver lobule. Fluids are then fed to other metabolic organs
such as SC-islet of Langerhans and SC-WAT. Potentially other SC-tissues can be added. Secreted
hormones and protein-lipid complexes are fed back to close the loop (feeding of intestinal segments not
shown for clarity of presentation). At each point, a fluid or food sample can be drawn, and SC-tissues are
available for biopsies. Important technical consideration such as waste collection and perfusion channels
are not shown in this schematic depiction.tissues in a bioengineered system will
be challenging. But considering the prog-
ress in the last decade in stem cell
and bioengineering fields, there is good
reason to believe that creating a physio-
logical, human-based model of digestion
is possible.
Incorporating Gut Microbes and
Food In Vitro
An in vitro human digestive system as
described above would only partially
model digestive physiology. Two other
important factors that need to be
incorporated are food itself and the gut
microbiota.
The human gut is populated by trillions
of bacteria from hundreds or thousands
of strains. Gut bacteria effectively form a
functional organ, composed of many mi-
crobial strains that interact with the hu-
man host and perform various metabolic
functions. The recognition of the impor-
tance of microbiota-host interactions is14 Cell 161, March 26, 2015 ª2015 Elsevier Icertainly not new; however, technological
advancements in DNA sequencing and
other methods have led to a booming in-
crease in our knowledge on this topic (Li
et al., 2014). As a result, digestion is now
understood to be a joint human-microbial
process. The food we eat nourishes not
only our organs, but also the microbial
community that we host.
The challenge of maintaining a micro-
bial ecosystem within the lumen of an
in vitro system is daunting. We are just
beginning to understand how to culture
gut microbial strains in a dish (Goodman
et al., 2011), but initial steps toward this
aim have beenmade. An advancedmodel
of a gut-on-a-chip, populated by the gut
anaerobic bacterium Lactobacillus rham-
nosus GG and human intestinal Caco-2
cells, has been developed. Co-culturing
bacteria and cells may be easier on a
chip due to the constant flow of nutrients
and differential culture conditions on the
luminal and apical side of the intestinalnc.epithelia (Kim et al., 2012; Kim and Ingber,
2013). We do not yet know if in vitro sys-
tems can or should host a full complement
of gut microbes, how such an ecosystem
can be inoculated and sustained in
culture, or what types of nutrients the
bacteria will require to model digestion
accurately.
In addition, the microbiota responds
dynamically to diet, perhaps more so
than the human gut. It changes with age
and has tight interactions with its host
through metabolites and the immune
system. It is also highly variable between
individuals and societies, representing a
major source of metabolic variability (Par-
frey and Knight, 2012). In vitromodeling of
the gut microbiome is still at early stages,
and some bacterial strains are not easily
cultured in the lab. Experimenting with
this system will teach us about human-
microbiota interactions and explore how
metabolic variability relates to micro-
biome composition.
In terms of food, the duodenum,
jejunum, ileum, and colon have different
digestive functions and encounter food
at different digestive stages. In vitro sys-
tems should be designed such that
hESC-derived intestinal segments form
separate chambers (Figure 1) that pass
food and chyme at various stages of
digestion through the lumen. Tailored
luminal culture conditions and chip me-
chanics will be required to support the
introduction of food and provide appro-
priate conditions for gut microbiota to
flourish.
Nutritional Data In Vitro and In Vivo
Nutrition science is a vast field integrating
biochemical, physiological, bioinformatic,
and cultural data. Mathematical modeling
and big data analysis are needed, as in
gut microbiota research, which includes
sequencing of multi-strain samples,
building statistical models of gut micro-
biota, and overlay of metabolic networks
with microbial enzymes. Breakthroughs
in microbiome research have been
made possible through collaborations be-
tween microbiologists, biochemists, and
computational biologists using system
biology approaches (Human Microbiome
Project Consortium, 2012).
Metabolomics, the high-throughput
mass spectrometry quantification of me-
tabolites in cells, organs, and body fluids,
benefits from the collaborative efforts
of biochemists and computational biolo-
gists, and the data analysis tools are com-
parable to those of sequencing and gene
expression (Melamud et al., 2010). In the
future, many more studies will likely use
metabolite profiling to describe the phys-
iology of human subjects in health and
disease, leading to discovery of novel
roles for metabolites and refining the
known metabolic networks at the cell
and organism-microbiota levels (Ryan
et al., 2014).
Similarly, nutrigenetics and nutrige-
nomics advance our understanding of
human metabolic variability using human
genetics and microbiome sequencing.
A classic example is the discovery that
mutations in the ldlr gene cause familial
hyperlipidemia. More recent efforts to
relate genetics, diet, and disease include
a series of biochemical and genome-
wide association studies aimed at
exploring connections between genetic
polymorphisms, red meat, and vegetable
consumption to the development of colo-
rectal cancer (Figueiredo et al., 2014). The
Segal and Elinav labs take a different
approach to understanding human meta-
bolic variability by measuring glucose
levels and food intake over the course of
a week and sequencing the gut micro-
biome of individuals. The results are fed
to a machine learning algorithm that
generates a personalized diet aimed at
reducing glucose spikes following meals
(www.personalnutrition.org).
Many tools and approaches developed
today will be instrumental for analyzing
the hESC based in vitro metabolic system
we envision. The various parameters influ-
encing metabolism can be well controlled
and, compared to in vivo studies, it should
be possible to collect high quality, repro-
ducible data. For example, we will be
able to sample fluids containing absorbed
metabolites from different positions in
the in vitro gut and understand how they
are affected by gut microbiota, a sudden
change in diet, antibiotics, or fasting and
feeding. Biopsies from the in vitro system
could teach us about the proteomic
and transcriptomic profile of the liver in
response to feeding, with high temporal
resolution. Alternatively, biopsies and
fluid samples may be obtained from the
system over a long period of time, without
worrying about the compliance of thepatient to the prescribed diet, effects
associated with the immune and nervous
systems of themodel organism, and other
uncontrolled variables.
Live imaging is much easier in vitro than
in vivo. Imaging metabolic or adaptive
processes is limited today to simple
in vitro cultures, or to snapshots from
in vivo models. Using hESC reporter lines,
one will be able to track the expression
of specific genes, cell composition,
secretion of factors, and changes in the
morphology of human tissues.
In all, the inherent complexity of nutri-
tion and digestion may be reduced and
dissected with a hESC-based in vitro sys-
tem. Access to high quality imaging, me-
tabolomics, and genomics data will allow
analysis of tractablemathematicalmodels
based on large data and testing of specific
biological hypotheseswithout the inherent
difficulties of immortal cell lines.
Applications and Limitations of a
Human Stem-Cell-Based System
An in vitro, complex stem-cell-based sys-
tem can fill the gap between an animal
in vivo model and cell lines, but cannot
model the full complexity of an in vivo sce-
nario and is not as straightforward as a
cell line or primary culture. However, it
can complement existing models and
human studies and create an opportunity
to better address physiological and nutri-
tional questions.
The ability to use iPSCs and genome
editing technology has been already put
to effective use for disease modeling
(Rashid et al., 2010; Wang et al., 2014).
A stem-cell-based system can be used
to study nutritionally related diseases.
For example, several genes have been
associated with intestinal inflammatory
diseases, but the role of only a handful
of genes has been elucidated (Murthy
et al., 2014). It is not known whether
changes in the immune system, the intes-
tine at large, or gut microbiota triggers
disease in genetically susceptible pa-
tients. More generally, the ability to genet-
ically modify stem cells that are used to
make tissues and organs will be enor-
mously valuable in determining which
genes function in which cells to affect
phenotype. The advances in gene modifi-
cation in this regard are all in place, mak-
ing it possible to test both loss and gain of
function for specific genes.Cell 1An in vitro system has applications for
screens of food additives or synbiotics.
Currently, studies are done on cell lines,
using mice or cohorts of humans, and
are not practical for the challenge. For
example, howwould we test which bacte-
rial strains are most efficient at digestion
of complex carbohydrates? Numerous
combinations of bacterial strains should
be tested in several dietary conditions
and human genetic backgrounds. Such
experiments would require thousands
of mice, but an in vitro system might
be scaled up for the task. Similarly, a
controlled system is ideal for studies on
the uptake of food and drugs. The differ-
ences between model organisms and hu-
mans become crucial in studying drug
metabolism, and an in vitro system might
better model drug metabolism, improving
the efficiency of drug development.
We envision through this system will
address many puzzles in the physiology
of digestion. Wewill be able to watch bac-
teria break down food and pass meta-
bolites to enterocytes, measure the level
of hormones as they are secreted, and
watch the intestine and microbiota adapt
to a change in diet. It should be possible
to model the digestive track following bar-
iatric surgeries and study the positive and
negative effects of surgery onmetabolism
(Mingrone and Castagneto-Gissey, 2009).
It will also permit modeling of fecal trans-
plants in specific genetic backgrounds
and diseases.
Ultimately, our hope is that this in vitro
system will go beyond the physiology of
digestion into the field of nutrition. The
aforementioned unanswered questions
in nutrition involve the long term effects
of diet, but currently organs-on-chips
have been limited to shorter time scales
on the order of weeks. This limitation
makes such systems less valuable for
the study of long term processes such
as chronic disease development. How-
ever, if indeed the in vitro system can sus-
tain cultures for longer periods of time,
one could follow the metabolic profile of
tissues following long term exposure to
a specific diet. One could capture the
development of insulin resistance in a
tissue as a function of diet in a system
simple enough to isolate in vivo effects
exerted by the immune and nervous sys-
tem, but complex enough to capture mi-
cro-environmental effects, such as liver61, March 26, 2015 ª2015 Elsevier Inc. 15
zonation. Similarly, we could compare the
long term effects of high carbohydrate
versus high protein diets on two initially
equivalent systems. These data will be
instrumental in understanding the mecha-
nisms underlying epidemiological and
nutritional observations in human sub-
jects (Qatanani and Lazar, 2007).
Nutritional questions that have been
raised recently, such as the advantages
in organic foods or the effects of artificial
sweeteners, could be addressed directly.
Mice studies are illuminating, but
currently, there is not sufficient human
data to draw conclusions (Gardner et al.,
2012; Suez et al., 2014). By using a hu-
man-based system and data of high qual-
ity and resolution, we might be able to
construct better full scale tests on human
subjects, and understand the mecha-
nisms by which sweeteners, both natural
and artificial, affect our long-term risk to
develop type 2 diabetes. We could feed
a stem-cell-based system with organic
versus non-organic food, and compare
the metabolic effects on human tissues
and microbiota in a controlled setting
(Baranski et al., 2014; Nature Editors,
2014), then propose better hypotheses
and design new experiments onmodel or-
ganisms and human subjects. Ultimately,
an in vitro system could support decisions
made daily by clinical nutritionists.
There are, or course, inherent limita-
tions to such an in vitro system. It does
not recapitulate all aspects of organ phys-
iology; for example, the nervous and
immune systems may prove difficult to
integrate into this system. The effects of
nutrition on organs such as the heart will
require an addition of a heart-on-a-chip
or other compatible systems (Wang
et al., 2014). An in vitro model will be
smaller by 2–3 orders of magnitude than
the human gut, and this physical differ-
ence limits the ability to model all physical
and chemical processes. Finally, the
engineering challenges in manufacturing
and handling these systems may keep
them from being widely applied.
Conclusions
The phrase ‘‘an apple a day keeps the
doctor away’’ speaks to a link between
nutrition and health. However, as a
scientific community we have yet to
answer comprehensively basic questions
in the science of nutrition. Human nutrition16 Cell 161, March 26, 2015 ª2015 Elsevier Iis difficult to study because of its
complexity, variability between individ-
uals, and human’s new foods and unique
eating habits and physiology. Despite
hurdles and bottlenecks, the generation
of complex, stem-cell-based in vitro sys-
tems simulating physiological processes
is just around the corner. We believe that
the approach outlined here will allow us
to begin to answer some basic, practical
questions about how nutrition affects
our immediate health, behavior, and the
development of disease. Who is prone to
gain weight and why? What is a healthy
diet and how might this differ from one
person to another? Nutrition scientists
have good answers to some of these
questions based on epidemiological
data and controlled animal and human
studies, but these answers lack mecha-
nistic understanding and may not apply
to specific individuals. Ultimately, we are
faced with a staggeringly simple and vital
question: what shouldwe have for dinner?
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